z-logo
Premium
miR‐193: A new weapon against cancer
Author(s) -
Khordadmehr Monireh,
Shahbazi Roya,
Sadreddini Sanam,
Baradaran Behzad
Publication year - 2019
Publication title -
journal of cellular physiology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.529
H-Index - 174
eISSN - 1097-4652
pISSN - 0021-9541
DOI - 10.1002/jcp.28368
Subject(s) - microrna , biology , motility , metastasis , angiogenesis , disease , cell growth , suppressor , cancer , cancer research , apoptosis , gene , computational biology , microbiology and biotechnology , genetics , medicine
microRNAs (miRNAs) are known as a large group of short noncoding RNAs, which structurally consist of 19–22 nucleotides in length and functionally act as one of the main regulators of gene expression in important biological and physiological contexts like cell growth, apoptosis, proliferation, differentiation, movement (cell motility), and angiogenesis as well as disease formation and progression importantly in cancer cell invasion, migration, and metastasis. Among these notable tiny molecules, many studies recently presented the important role of the miR‐193 family comprising miR‐193a‐3p, miR‐193a‐5p, miR‐193b‐3p, and miR‐193b‐5p in health and disease biological processes by interaction with special targeting and signaling, which mainly contribute as a tumor suppressor. Therefore, in the present paper, we review the functional role of this miRNA family in both health and disease conditions focusing on various tumor developments, diagnoses, prognoses, and treatment.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here